Ethylene glycol monoethyl ether


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000014 Abnormalities, Drug-Induced PMID:6499796; PMID:6499812; PMID:6499820; PMID:6499823; PMID:7151721
MESH:D001259 Ataxia PMID:7151721
MESH:D001284 Atrophy PMID:15850284; PMID:6499799
MESH:D001724 Birth Weight PMID:2884743; PMID:6499823
MESH:D001836 Body Weight Changes PMID:6499796; PMID:7151721
MESH:D002764 Cholecystitis PMID:6499794
MESH:D003643 Death PMID:6499796
MESH:D005313 Fetal Death PMID:2884743; PMID:6499820; PMID:6499823; PMID:7151721; PMID:7198755
MESH:D005317 Fetal Growth Retardation PMID:6499796
MESH:D005327 Fetal Resorption PMID:6499812; PMID:6499820
MESH:D006402 Hematologic Diseases PMID:10514026; PMID:20172899
MESH:D006461 Hemolysis PMID:17874071; PMID:19051582
MESH:D007247 Infertility, Female PMID:6499823
MESH:D007248 Infertility, Male PMID:6499823
MESH:D009336 Necrosis PMID:20172899
MESH:D009845 Oligospermia PMID:20172899
MESH:D011297 Prenatal Exposure Delayed Effects PMID:2884743; PMID:6499817; PMID:7198755
MESH:D013276 Stomach Ulcer PMID:6499799
MESH:D013733 Testicular Diseases PMID:10048760; PMID:10514026; PMID:6499806
MESH:D020567 Fetal Weight PMID:2884743; PMID:6499820; PMID:7151721
MESH:D020964 Embryo Loss PMID:6499796
MESH:D053627 Asthenozoospermia PMID:10689203; PMID:6499807; PMID:6499823
MESH:D053713 Azoospermia PMID:6492198; PMID:6499807

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.